Evidence map›Paper›PMID 32955096›Full record

ArticleTranslational behavioral medicine2020

Introduction to the special series: translating behavioral medicine research to prevent and control the spread of COVID-19.

Alan M Delamater, Suzanne M Miller, Deborah J Bowen, Michael A Diefenbach, Kenneth P Tercyak

Abstract readEditorialComment
In one paragraph

Article in Translational behavioral medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Alan M DelamaterDepartment of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA.
Suzanne M MillerCancer Prevention and Control Program, Fox Chase Cancer Center/Temple University Health System, Philadelphia, PA, USA.
Deborah J BowenDepartment of Bioethics and Humanities, University of Washington, Seattle, WA, USA.
Michael A DiefenbachInstitute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Kenneth P TercyakGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHARNITA M. ZEIGLER-JOHNSON · 1985 to 2026
$138.8M
Recovery Support for Bladder CA Patients and Caregivers: A Multimodal ApproachR01CA224918 · NCI · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI DIEFENBACH, MICHAEL A, MILLER, SUZANNE M · 2018 to 2023
$3.5M
ACL HHS U01OH011690NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA224918
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Behavioral MedicineBetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralCOVID-19HumansSARS-CoV-2

Identifiers

PMID32955096
PMCPMC7543073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.